A 3-Month, Randomised, Open-Label, Parallel-Group, Descriptive Study To Explore And Compare Perceptions and Satisfaction For Two Different Delivery Mechanisms For Etanercept (Etanercept Autoinjector And The Etanercept Prefilled Syringe) In Patients With Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 27 Mar 2013
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Wyeth
- 03 Jul 2012 Planned number of patients changed from 534 to 724 as reported by European Clinical Trials Database record.
- 09 Jun 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.